The Th17 and Autoimmune Arthritis
![]() |
Cho, Mi-La
(Rheumatism Research Center (RhRC), The Catholic University of Korea)
Heo, Yu-Jung (Rheumatism Research Center (RhRC), The Catholic University of Korea) Park, Jin-Sil (Rheumatism Research Center (RhRC), The Catholic University of Korea) Lee, Seon-Yeong (Rheumatism Research Center (RhRC), The Catholic University of Korea) Sung, Young-Chul (Biotech Center, Department of Life Science, Pohang University of Science and Technology) Kim, Ho-Youn (Rheumatism Research Center (RhRC), The Catholic University of Korea) |
1 | Nishimoto N: Cytokine signal regulation and autoimmune disorders. Autoimmunity 38;359-367, 2005 DOI ScienceOn |
2 | Laura Connell: New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20;865-878, 2006 DOI ScienceOn |
3 | Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Immunology 18;349-356, 2006 |
4 | Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA: IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23;513-522, 2003 DOI ScienceOn |
5 | Constantinescu CS, Wysocka M, Hilliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A: Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 161;5097-5104, 1998 PUBMED |
6 | Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201;233-240, 2005 DOI ScienceOn |
7 | Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278;1910-1914, 2003 DOI ScienceOn |
8 | Wolk, K, Sabat R: Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17;367-380, 2006 DOI ScienceOn |
9 | Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ: Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116; 1317-1326, 2006 DOI ScienceOn |
10 |
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR: The orphan nuclear receptor ROR |
11 | Connell L, McInnes IB: New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20;865-878, 2006 DOI ScienceOn |
12 | Fujiwara M, Hirose K, Kagami S, Takatori H, Wakashin H, Tamachi T, Watanabe N, Saito Y, Iwamoto I, Nakajima H: T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol 119;662-670, 2007 DOI ScienceOn |
13 | Chabaud M, Durand J, Buchs N: Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42;963-970, 1999 DOI ScienceOn |
14 | Bau B, Haag J, Schmid E, Kaiser M, Gebhard PM, Aigner T: Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or downregulated in osteoarthritic cartilage. J Bone Miner Res 17; 2141-2150, 2002 DOI ScienceOn |
15 | Willenborg DO, Fordham S, Bernard C, CowdenWB, Ramshaw IA: IFN-gamma playsa critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157;3223-3227, 1996 PUBMED |
16 | Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6;1133-1141, 2005 DOI ScienceOn |
17 | Villarino AV, Huang E, Hunter CA: Understanding the proand anti-inflammatory properties of IL-27. J Immunol 173;715-20, 2004 DOI PUBMED |
18 | Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 116;1218-1222, 2006 DOI ScienceOn |
19 | Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H: Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203;2673-2682, 2006 DOI ScienceOn |
20 | Kim HR, Cho ML, Kim KW, Juhn JY, Hwang SY, Yoon CH, Park SH, Lee SH, Kim HY: Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPKdependent signalling pathways. Rheumatology (Oxford) 46; 57-64, 2007 DOI ScienceOn |
21 | Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF: Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36;2857-2867, 2006 DOI ScienceOn |
22 | Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16; 779-790, 2002 DOI ScienceOn |
23 | Marsland BJ, Nembrini C, Grun K, Reissmann R, Kurrer M, Leipner C, Kopf M: TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-{theta} signaling and promote autoimmune myocarditis. J Immunol 178;3466-3473, 2007 DOI |
24 | Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cellderived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42;963-970, 1999 DOI ScienceOn |
25 | Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 21;467-476, 2004 DOI ScienceOn |
26 | Lundy SK, Sarkar S, Tesmer LA, Fox DA: Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 13;202, 2007 |
27 |
Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN- |
28 | Clavel G, Valvason C, Yamaoka K, Lemeiter D, Laroche L, Boissier MC, Bessis N: Relationshipbetween angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 17;202-210, 2006 PUBMED |
29 | Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89;587-596, 1997 DOI ScienceOn |
30 | Stamp LK, James MJ, Cleland LG: Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol Cell Biol 82;1-9, 2004 DOI ScienceOn |
31 | Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y: IL-17 stimulates inflammatory responses via NF- kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 282;G1035-G1044, 2002 DOI |
32 | Findlay DM, Haynes DR: Mechanisms of bone loss in rheumatoid arthritis. Mod Rheumatol Aug 15;232-240, 2005 DOI |
33 | Olsen NJ, Stein CM: New drugs for rheumatoid arthritis. N Engl J Med 350;2167-2179, 2004 DOI ScienceOn |
34 | Moseley TA, Haudenschild DR, Rose L, Reddi AH: Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14;155-174, 2003 DOI ScienceOn |
35 |
Hwang SY, Kim JY, Kim KW, Park MK, Moon YM, Kim WU, Kim HY: IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF- |
36 | Koller MD: Targeted therapy in rheumatoid arthritis. Wien Med Wochenschr 156;53-60, 2006 DOI ScienceOn |
37 |
Nakae S, Iwakura Y, Suto H, Galli SJ: Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007 Heremans H, Dillien C, Groenen M, Martens E, Billiau A: Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon- |
38 | Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 116;1218-1222, 2006 DOI ScienceOn |
39 | Afzali B, Lombardi G, Lechler RI, Lord GM: The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 148;32-46, 2007 DOI PUBMED ScienceOn |
40 | Lubbets E, Koenders MI, van den Berg WB: The role of T-cell interukine-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7;29-37, 2005 DOI ScienceOn |
41 | Bettelli E, Kuchroo VK: IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 201;169-171, 2005 DOI ScienceOn |
42 | Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17;138-146, 1996 DOI ScienceOn |
43 | Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6;1133-1141, 2005 DOI ScienceOn |
44 | Aggarwal S, Gurney AL: IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 71;1-8, 2002 PUBMED |
45 | Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K,Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44;1003-1012, 2001 DOI ScienceOn |
46 |
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGF |
47 | Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 8;445:648-651, 2007 DOI ScienceOn |
48 | Leonard JP, Waldburger KE, Goldman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181;381-386, 1995 DOI |
49 | Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S:T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183;2593-2603, 1996 DOI ScienceOn |
50 | Lubberts E, Koenders MI, van den Berg WB: The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7;29-37, 2005 DOI ScienceOn |
51 | Frohlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, Harris NL, Kopf M: IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109;2023-2031, 2007 DOI ScienceOn |
52 | Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441;235-238, 2006 DOI ScienceOn |
53 | Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, Blumenschein WM, McClanahan T, Brombacher F, Hurst SD, Kastelein RA, Cua DJ: IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204;161-170, 2007 DOI ScienceOn |
54 | Martinus AM, van Boekel, Erik R Vossenaar, Frank HJ van den Hoogenand WaltherJvan Venrooij: Autoantibody systems in rheumatoid arthritis: specificity,sensitivity and diagnostic value. Arthritis Res 4;87-93, 2002 PUBMED |
55 | Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156;5-7, 1996 PUBMED |
56 | Beklen A, Ainola M, Hukkanen M, Gurgan C, Sorsa T, Konttinen YT: MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 86;347-351, 2007 DOI ScienceOn |
57 | Muller-Ladner U, Pap T: Pathogenesis of RA: more than just immune cells. Z Rheumatol 64;396-401, 2005 DOI |
58 | Estelle Bettelli, Mohamed Oukka, Vijay K Kuchroo1: T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8;345-50, 2007 DOI ScienceOn |
59 | Farber A, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156;5-87, 1996 PUBMED |
60 | Andoh A, Hata K, Araki Y, Fujiyama Y, Bamba T: Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts, Int J Mol Med 10;631-634, 2002c PUBMED |
61 | Chung Y, Yang X, Chang SH, Ma L, Tian Q, Dong C: Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res 16;902-907, 2006 DOI ScienceOn |
62 | McGeachy MJ, Anderton SM: Cytokines in the induction and resolution of expermental autoimmune encephalomyelitis. Cytokine 32;81-84, 2005 DOI ScienceOn |
63 | Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH, Kim HY: Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaBdependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 7;139-148, 2005 |
64 | Andoh, S. Fujino, S. Bamba, Y. Araki, T. Okuno and T. Bamba: IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts, J Immunol 169;1683-1687, 2002a DOI PUBMED |
65 | Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445;648-651, 2007 DOI ScienceOn |
66 | Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6;1123- 1132, 2005 DOI ScienceOn |
67 | Andoh S, Fujino T, Okuno Y, Fujiyama Y, Bamba T: Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J Gastroenterol 37;33-37, 2002b PUBMED |
68 | Georg Schett: Rheumatoid arthritis: inflammation and bone loss. Wien Med Wochenschr 156;34-41, 2006 DOI |
69 | Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Macrophages in rheumatoid arthritis. Histol Histopathol 22;581-586, 2007 PUBMED |
70 | Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM: IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175;788-795, 2005 DOI |
71 | Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50;650-659, 2004 DOI ScienceOn |
72 | Kageyama Y, Koide Y, Yoshida A, Uchijima M, Arai T, Miyamoto S, Ozeki T, Hiyoshi M, Kushida K, Inoue T: Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161;1542-1548, 1998 PUBMED |
73 | Knauer J, Siegemund S, Muller U, Al-Robaiy S, Kastelein RA, Alber G, Straubinger RK: Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells. FEMS Immunol Med Microbiol 49;353-363, 2007 DOI ScienceOn |
74 | Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick DJ: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. Clin Invest 116;1310-1316, 2006 DOI ScienceOn |
75 |
Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Maththys P: Accelerated collagen-induced arthritis in IFN |
![]() |